ACM
GDRX icon

AlphaCrest Capital Management’s GoodRx Holdings GDRX Stock Holding History

AlphaCrest Capital Management’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-317,178
Closed -$1.88M – 1309
2022
Q2 		$1.88M Buy
317,178
+231,592
+271% +$2.58M 0.09% 346
2022
Q1 		$1.65M Buy
+85,586
New +$1.96M 0.09% 314

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCMX
Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

AlphaCrest Capital Management's GDRX Position: Q3 2022 in Review

AlphaCrest Capital Management sold out of GoodRx Holdings (GDRX) in Q3 2022, closing a stake of 317,178 shares — an estimated $1.88M sold.

AlphaCrest Capital Management first reported a position in GDRX in Q1 2022 and held it in 2 quarters. The position peaked at $1.88M in Q2 2022. 180 funds tracked by Wall St. Rank hold GDRX as of Q3 2022.

  • AlphaCrest Capital Management reported no remaining GoodRx Holdings position as of Q3 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 317,178 GoodRx Holdings shares in Q3 2022, an estimated $1.88M.
  • AlphaCrest Capital Management first reported a position in GoodRx Holdings in Q1 2022 and held it in 2 quarters.
  • AlphaCrest Capital Management's GoodRx Holdings position peaked at $1.88M in Q2 2022.
  • 180 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2022.

Based on AlphaCrest Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.